SCHEMBL22317545

SCHEMBL22317545

B[C@@H]1O[C@H](COC)C(OC)C1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14537229 1.00 — —
SCHEMBL14295971 1.00 — —
SCHEMBL16943046 0.85 — —
SCHEMBL26652153 0.82 FGF1 (0.33) —
SCHEMBL10310995 0.82 FGF1 (0.33) —
SCHEMBL13222901 0.82 FGF1 (0.33) —
SCHEMBL12253802 0.82 FGF1 (0.33) —
SCHEMBL10001262 0.82 FGF1 (0.33) —
SCHEMBL20329200 0.82 — —
SCHEMBL26474211 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11566070-B2 Agents that modulate TMEM230 as angiogenesis regulators and that detect TMEM230 as markers of metastasis CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2023-01-31 — — US disclosed
US-20200247882-A1 AGENTS THAT MODULATE TMEM230 AS ANGIOGENESIS REGULATORS AND THAT DETECT TMEM230 AS MARKERS OF METASTASIS REINBOLD, Rolland Alvons (IT) 2020-08-06 — — US disclosed
Send feedback